News

FDA panel is split on updates to COVID shots as questions loom for fall vaccinations
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
COVID Shots Should Target Newer Strains of JN.1 Variant in 2025-26 Campaign, US FDA Advisers Say
(Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of recommending that ...
FDA to limit covid shot approval to 65+, those with medical conditions
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
New Trump vaccine policy limits access to COVID shots
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
FDA may limit future Covid-19 shots to older people and those at risk of serious infection
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
Explore more
US FDA Advisers to Consider if New COVID Shots Should Target LP.8.1 Subvariant
The LP.8.1 strain, a subvariant of the JN.1 strain that was targeted last year, has begun spreading at a faster rate than ...
Public Broadcasting Service (PBS)1d
Who is eligible for a COVID shot? What to know about the FDA’s latest changes
The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months ...